Skip to main content
Metformin tied to improved CV function in youths with type 1 diabetes
7/15/2019

A randomized study of 48 adolescents with type 1 diabetes, presented at the Heart in Diabetes conference, showed that those who received 2,000 mg of metformin daily for three months had reduced pulse wave velocity, reduced aortic wall sheer stress and improved far-wall diastolic carotid intima-media thickness, compared with those on placebo. Researchers also found that metformin users had improved glucose infusion rate, reduced fat mass and reduced body weight compared with the placebo group.

Full Story: